Engineers Gate Manager LP Ironwood Pharmaceuticals Inc Transaction History

Engineers Gate Manager LP

$4.86 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.58 - $8.61 $516,267 - $796,605	-92,521 Reduced 73.68%	33,046 $215,000
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $150,001 - $278,548	18,029 Added 16.77%	125,567 $1.09 Million
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $945,259 - $1.24 Million	107,538 New	107,538 $1.23 Million
Q2 2023 Aug 14, 2023	SELL	$10.1 - $11.6 $651,823 - $748,629	-64,537 Reduced 79.82%	16,313 $173,000
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $568,825 - $688,953	54,853 Added 211.0%	80,850 $850,000
Q4 2022 Feb 14, 2023	SELL	$9.9 - $12.43 $114,741 - $144,063	-11,590 Reduced 30.84%	25,997 $322,000
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $138,583 - $169,197	13,667 Added 57.14%	37,587 $389,000
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $264,316 - $304,262	23,920 New	23,920 $276,000
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $1.1 Million - $1.33 Million	-103,527 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $1.12 Million - $1.44 Million	103,527 New	103,527 $1.21 Million
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $906,635 - $1.06 Million	-76,060 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.16 - $13.11 $555,670 - $717,012	54,692 Added 255.95%	76,060 $979,000
Q1 2021 May 17, 2021	SELL	$9.04 - $11.86 $670,171 - $879,229	-74,134 Reduced 77.63%	21,368 $239,000
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $1.21 Million - $1.63 Million	-133,703 Reduced 58.33%	95,502 $1.09 Million
Q3 2020 Nov 16, 2020	BUY	$8.99 - $10.74 $893,084 - $1.07 Million	99,342 Added 76.5%	229,205 $2.06 Million
Q2 2020 Aug 17, 2020	BUY	$9.14 - $11.97 $1.19 Million - $1.55 Million	129,863 New	129,863 $1.34 Million
Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $2.27 Million - $3.71 Million	-264,889 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $1.51 Million - $2.57 Million	183,508 Added 225.49%	264,889 $3.53 Million
Q3 2019 Nov 14, 2019	BUY	$8.59 - $10.96 $699,062 - $891,935	81,381 New	81,381 $699,000
Q2 2019 Aug 14, 2019	SELL	$9.8 - $12.89 $2.2 Million - $2.9 Million	-224,618 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$8.27 - $12.73 $669,745 - $1.03 Million	80,985 Added 56.38%	224,618 $3.04 Million
Q4 2018 Feb 14, 2019	BUY	$7.8 - $16.13 $376,396 - $778,369	48,256 Added 50.6%	143,633 $1.49 Million
Q3 2018 Nov 01, 2018	BUY	$14.31 - $17.65 $1.36 Million - $1.68 Million	95,377 New	95,377 $1.76 Million
Q2 2018 Aug 03, 2018	SELL	$11.83 - $16.2 $1.32 Million - $1.81 Million	-111,861 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$11.13 - $13.63 $1.25 Million - $1.52 Million	111,861 New	111,861 $1.73 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$96.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$92.8 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$69 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$47.5 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$41.8 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $645M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account